STRAUSS GROUP LTD. (STRS)
Results of the general meeting dated 30.4.26
Results of the general meeting dated 30.4.26
Dividend - complementary report
La Comisión Europea (CE) aprueba POHERDY® (pertuzumab) de Henlius y Organon, el primer biosimilar de PERJETA (pertuzumab) autorizado en Europa
FDA ODAC vote on camizestrant in breast cancer
Europäische Kommission erteilt Marktzulassung für POHERDY® (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab)
La Commissione Europea (CE) approva POHERDY® (pertuzumab), messo a punto da Henlius e Organon, il primo biosimilare di PERJETA (pertuzumab) approvato in Europa
Northfield Bancorp Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Northfield Bancorp, Inc. - NFBK
Thermon Group Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thermon Group Holdings, Inc. - THR
CrowdStrike Puts Claude Opus 4.7 to Work Across the Falcon Platform and Project QuiltWorks
Webster Financial Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Webster Financial Corporation - WBS